Dr Paulo Rocha is developing a low-cost integrative sensing tool for early...
Dr Paulo Rocha is developing a low-cost integrative sensing tool for early detection of Dengue virus, using a novel platform containing electrical sensors to investigate the behaviour of human cells infected with Dengue virus.

Source: University of Bath

News • Infectious disease

Sensor technology could detect Dengue fever earlier

Researchers from the University of Bath are developing a new tool for detecting the presence of Dengue fever early on, helping prevent people from suffering potential life-threatening complications.

Dr Paulo Rocha from the University of Bath’s Department of Electronic & Electrical Engineering is developing a low-cost integrative sensing tool for early detection of Dengue virus, using a novel platform containing electrical sensors to investigate the behaviour of human cells infected with Dengue virus.

When someone is infected by the Dengue virus it produces proteins, particularly ‘non-structural protein 1’ (NS1) which is secreted from infected cells. Using a three centimetre squared platform, the Bath-based research team will observe the electrical behaviour of human cells in vitro infected by different concentrations of NS1. A better understanding of the electrical behaviour of these cells, the researchers believe, will help create a more accurate and sensitive way of detecting the presence of Dengue virus.

In the future, it is hoped this research will lead to the development of a low cost, disposable, real time wearable system for detecting Dengue fever as well as Zika virus and Yellow Fever virus, both of which belong to the same Flaviviridae family. This will be of particular benefit to communities in developing countries where access to healthcare may be limited and Dengue fever is particularly prevalent.

Dengue fever is an incurable mosquito-borne tropical disease initiated by the Dengue virus. It is spread by mosquitos mostly in tropical and subtropical areas of the world with symptoms ranging from fever and muscle/joint pains to life threatening Dengue hemorrhagic fever. Each year it is estimated 390 million dengue infections occur around the world. Of these, 500,000 cases develop into dengue haemorrhagic fever which results in up to 25,000 deaths annually worldwide.

A method that doctors currently adopt to test for Dengue fever is by examining the presence of NS1 in a patient’s bloodstream through a simple blood test. However, many people who are infected by Dengue virus may not be diagnosed due to the concentration of NS1 being so low and therefore not detected. This prevents correct diagnosis and the early intervention of drugs to counteract and reduce the effects of the virus. "If we can detect Dengue fever earlier on, we can ultimately efficiently treat a person’s symptoms and prevent the virus from developing into a more serious infection. By determining if there is a correlation with a cell’s electrical signal and the presence – no matter how little the concentration – of NS1, we can identify if someone is infected with Dengue virus earlier," said Dr. Rocha.

Source: University of Bath

20.03.2019

Read all latest stories

Related articles

Photo

News • Diagnostics

Heat it and read it

You’re sweating and feverish and have no idea why. Fortunately, Sandia National Laboratories scientists have built a device that can pinpoint what’s wrong in less than an hour. Unlike most…

Photo

News • Multiplex immunoassay

Dengue Fever: hope for low-cost diagnostics

Accurate home testing could be used for a wider range of illnesses, as new research shows the capability of smartphone-powered tests for Dengue Fever.

Photo

News • Adaptable for screening

An optical methodology for rapid detection of COVID-19

The tool has made it possible to detect SARS-CoV-2 in exudate from symptomatic patients with a sensitivity of 100% and a specificity of 87.5%

Related products

Lifotronic - FA-160 Immunofluorescence Analyzer

Immunoassays

Lifotronic - FA-160 Immunofluorescence Analyzer

Lifotronic Technology Co., Ltd
Nova Biomedical – StatStrip Glucose/Ketone*

Blood Glucose

Nova Biomedical – StatStrip Glucose/Ketone*

Nova Biomedical Corporation
Sarstedt – Tempus600 Vita

Sample Logistics

Sarstedt – Tempus600 Vita

SARSTEDT AG & CO. KG
Alsachim - Dosimmune immunosupressant Alsachim – kit (CE-IVD or RUO)

Clinical Chemistry

Alsachim - Dosimmune immunosupressant Alsachim – kit (CE-IVD or RUO)

Alsachim, a Shimadzu Group Company
Subscribe to Newsletter